Medknow Publications, Asian Journal of Andrology, 4(14), p. 522-524, 2012
DOI: 10.1038/aja.2012.50
Full text: Download
An updated result of European Randomized Screening Trial for Prostate Cancer encourages Asian countries to proceed prostate-specific antigen (PSA) screening for early detection. On the other hand, the issue of overtreatment is emerging as a serious problem. Active surveillance (AS) should be more prevalent than now to avoid overtreatment for patients with favourablerisk prostate cancer (PCa) detected by PSA test.